Immunoglobulins treatment in multiple sclerosis and experimental autoimmune encephalomyelitis

Multiple Sclerosis

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Achiron, A ^a   Miron, S ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Experimental autoimmune encephalomyelitis; Immunoglobulins; Multiple sclerosis; Treatment

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C9; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; LYMPHOTOXIN; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; CELL LINE; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DEMYELINATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MONOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; REMYELINIZATION; T LYMPHOCYTE ACTIVATION;

EID: 0033758129     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850000602s02     Document Type: Conference Paper

References (28)

1. Management of relapsing-remitting multiple sclerosis: Diagnosis and treatment guidelines
2. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
3. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
4. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis
5. Complications of intravenous immune globulin treatment in Neurologic disease
6. Myelin basic protein-specific T-cell clones and experimental allergic encephalomyelitis
7. Adoptive transfer of myelin basic protein-synthesized T-cells produce chronic relapsing demyelinating disease in mice
8. Intravenous immunoglobulin treatment of experimental T-cell mediated autoimmune diseases: Up-regulation of T-cell proliferation and down-regulation of TNF-a secretion
9. Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin therapy
10. Pooled human IgG modulates cytokine production in lymphocytes and monocytes
11. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
12. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice
13. In vivo relationship of tumor necrosis factor-a to blood-brain barrier damage in patients with active multiple sclerosis
14. Limited heterogeneity of T-cell receptors from T lymphoctes mediating autoimmune encephalomyelitis allows specific immune intervention
15. Mechanisms of action of intravenous immune globulin in immune-mediated diseases
16. Synthetic peptides of human CD4 enhance binding of immunoglobulins to monocyte/macrophages cells. II. Mechanisms of enhancement
17. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro
18. In vitro effects of an immunoglobulin preparation for intravenous use (IVIG) on T-cells activation
19. Effect of various plasma preparations and i.v. immunoglobulins on the function of lymphocytes and monocytes in vitro
20. Role of autoreactive CD8+ T-cells in organ-specific autoimmune disease: Inssight from transgenic mouse
21. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease
22. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
23. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin oligodendrocyte glycoprotein
24. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
25. High dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
26. Immunoglobulins promote remyelination in the central nervous system
27. Immunoglobulins stimulate central nervous system remyelination: Electron microscopic and morphometric analysis of proliferating cells
28. Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes